We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SKBL:NASDAQSkyline Builders Group Holding Limited Analysis

Data as of 2026-05-01 - not real-time

$4.55

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Skyline Builders Group Holding Limited is trading at the upper end of its 20‑day SMA (4.55 vs 3.58) with the 20‑day SMA still above the 50‑day and 200‑day averages, indicating a short‑term bullish bias. Momentum is extremely strong – RSI sits at 73 and the MACD line is above its signal, producing a bullish histogram. However, the stock is massively overvalued (trailing P/E ≈ 227 versus an industry average of ~31) and the company’s fundamentals are weak: gross margin under 7 %, operating cash flow negative, and a historic max drawdown of –96 %. Recent material news adds further uncertainty – a private placement of convertible notes and preferred shares was announced, while a securities class‑action investigation has been publicized, creating potential legal headwinds.
Given the high beta (≈1.84), 30‑day volatility above 75 %, and modest revenue growth (≈6 %), the upside from technical momentum is likely to be limited and could be eclipsed by valuation pressure, cash‑flow constraints, and the pending litigation. Investors should treat SKBL as a high‑risk, overvalued play with limited upside potential unless the company can quickly improve profitability or resolve the legal issues.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • RSI overbought at 73
  • Extreme overvaluation (P/E 227)
  • Pending securities class‑action investigation

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Bullish technicals (MACD, SMA alignment)
  • Increasing volume trend
  • Weak cash flow and high debt burden

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Sustained high volatility and beta
  • Negative free cash flow and large drawdown risk
  • Fundamental mismatch between price and earnings

Key Metrics & Analysis

Financial Health

Revenue Growth6.30%
Profit Margin1.34%
P/E Ratio227.5
ROE5.87%
ROA1.88%
Debt/Equity66.53
P/B Ratio3.3
Op. Cash Flow$-2745339
Free Cash Flow$-4265756
Industry P/E31.5

Technical Analysis

TrendBullish
RSI73.1
Support$2.41
Resistance$4.55
MA 20$3.58
MA 50$3.27
MA 200$2.68
MACDBullish
VolumeIncreasing
Fear & Greed Index90.89

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta1.84
Volatility75.23%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.